Follow The Filings

JBIO position history

The shares of Jade Biosciences (JBIO) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM NEW

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q4: 855,216 shares, $13M, 1.7% of portfolio, New
  2. 2026 Q1: 427,608 shares, $6M, 0.79% of portfolio, Reduce −50.0%
  3. 2026 Q2: 145,000 shares, $3.2M, 0.29% of portfolio, Reduce −66.1%
Holdings date Value % of holdings Shares Filing date All 13F holders